Breaks Categories: Stock Spotlights

TuesdayDec 26, 2017 12:38 pm

CannabisNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Centers Focus on Cryptocurrency Division

ChineseInvestors.com, Inc. (OTCQB: CIIX), a diverse educational and consulting company for the Chinese-speaking community in China and the U.S., recently announced that it is spinning off two divisions to allow itself to focus on its new cryptocurrency division. The company is spinning off its wholly-owned foreign entity, CBD Biotechnology Co., Ltd., and its wholly-owned subsidiary, ChineseHempOil.com. An article discussing plans this reads: “It has committed itself to cryptocurrency education and active involvement. It broadcasts a daily video from the NYSE titled ‘Bitcoin MultiMillionaire’. It has also recently reached agreement to host a bitcoin ATM in the lobby of its headquarters…

Continue Reading

FridayDec 22, 2017 12:18 pm

CannabisNewsBreaks – Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) to Leverage Unique Compound Synergies for Pain Moderation

Based on evidence that cannabinoids and opioids can work in synergy to moderate pain, Veritas Pharma (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) and its research arm, Cannevert Therapeutics Ltd., intend to boost actions of opioid analgesics with a specific strain of cannabis. A recent article highlights the company’s approach in developing quality strains, stating, “Veritas Pharma employs a scientific approach to support medical cannabis claims and is intent on developing and commercializing the most effective strains of cannabis for medical use. The company is concerned that, with the rapid growth of the medical cannabis industry, product quality is inconsistent and…

Continue Reading

ThursdayDec 21, 2017 3:08 pm

CannabisNewsBreaks – Cryptocurrency Integration Creates New Opportunities for Medical Cannabis Payment Solutions (REFG)

Medical Cannabis Payment Solutions’ (OTC: REFG) adoption of cryptocurrency (“$Weed”) through a partnership with First Bitcoin Capital Corporation (OTC: BITCF) is giving the leader in end-to-end management of marijuana industry operations a significant resource as it strives to enable legal and compliant cannabis companies with options for their success. America’s medical cannabis industry is expected to grow at double digit rates in the years to come. An article discussing this reads: “Through the collaboration, dispensaries and other companies that work in the marijuana industry will gain another opportunity for payment processing. They will work with both debit cards and prominent…

Continue Reading

ThursdayDec 21, 2017 12:56 pm

CannabisNewsBreaks – Marijuana Company of America, Inc. (MCOA) Poised for Action in Cannabinoid Health Industry

Amid the industry and consumer enthusiasm accompanying the expansion of marijuana product legalization throughout the United States and across the globe, the Marijuana Company of America (OTC: MCOA) is preparing to develop and market hemp-derived nutritional and wellness products. MCOA’s subsidiary hempSMART is committed to producing clinically tried cannabinoid formulations and delivering them through a convenient and discreet network. An article discussing this reads: “hempSMART places a high priority on using the best quality extracts from hemp plants that are produced and processed to maximize cannabinoid concentration and potency. The company currently has two CBD-based products available for distribution. The…

Continue Reading

ThursdayDec 21, 2017 12:47 pm

CannabisNewsBreaks – Skinvisible, Inc. (SKVI) May Target Booming Pain Management Market Through Proposed Merger with Quoin Pharmaceuticals

Topical and transdermal product development company Skinvisible (OTCQB: SKVI) recently signed a Letter of Intent (“LOI”) regarding a proposed merger with Quoin Pharmaceuticals Limited. The potential partnership could target significant unmet medical needs on the pain management market. An article discussing this reads: “Currently, the pain management market in the U.S. is fueled by a number of sectors. The most prominent ones include post-operative pain relief, arthritis pain, cancer pain, migraine and neuropathic pain. As larger Western populations age and become susceptible to an array of medical conditions, the need for new pain management developments will grow even larger. The…

Continue Reading

FridayDec 15, 2017 1:07 pm

CannabisNewsBreaks – Medical Cannabis Payment Solutions (REFG) Offers Cashflow Alternatives for Cannabis Industry

Wyoming’s Medical Cannabis Payment Solutions (OTC: REFG) has established a pioneering method of merchant processing that sustains industry businesses and is compliant with the U.S. federal government’s laws in their current state. REFG’s subsidiary StateSourced provides an alternative payment method for companies unable to work with banks in tracking sales and tax collections for cannabis-related products because of the Controlled Substance Act. An article discussing this reads: “Medical Cannabis Payment Solutions and its StateSourced specialized digital payment platform ensures full compliance with all laws affecting the cannabis industry while delivering full-spectrum merchant processing services (http://cnw.fm/tKb6U). Medical Cannabis Payment Solutions is…

Continue Reading

FridayDec 15, 2017 12:58 pm

CannabisNewsBreaks – Skinvisible, Inc. (SKVI) Advances Invisicare Delivery System

Topical and transdermal product development company Skinvisible (OTCQB: SKVI) is targeting the pharmaceutical industry with its proprietary drug delivery system, Invisicare. Invisicare improves the delivery of ingredients to and through the skin. An article discussing this reads: “Skinvisible has developed over 40 product formulations using Invisicare both in the medical and skincare markets, in addition to being granted 14 patents. The company is focused on licensing its formulations and Invisicare to other companies in the pharmaceutical and cosmeceutical industries. The company’s business model emphasizes four revenue streams that include fees for new product development, license fees, sales of branded products,…

Continue Reading

TuesdayDec 12, 2017 1:56 pm

CannabisNewsBreaks – Global Payout, Inc. (GOHE) Directed by Executive Talent and Experience

Global Payout (OTC: GOHE) has distinguished itself as a premier global payment solutions provider lead by a seasoned executive team. An article discussing this reads: “Founder James Hancock, CEO and chairman of the board of Global Payout, has over thirty years’ experience in multiple executive capacities in financial services, investment banking, mergers and acquisitions, telecommunications and payment processing. Prior to founding Global Payout, Hancock, who holds a Juris Doctorate from the California School of Law, specialized in the financial services sector for 14 years and launched nearly 40 custom-designed prepaid debit card programs. Operating as a prepaid card services company,…

Continue Reading

MondayDec 11, 2017 5:16 pm

CannabisNewsBreaks – Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Develops Cannabis-Based Therapeutics in Response to Opioid Epidemic

Emerging pharmaceutical and IP development company Veritas Pharma (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) is using scientific research and development to stake out its spot in the medical marijuana industry. An article discussing this reads: “Veritas Pharma’s mission is to develop and commercialize the most effective cannabis strains, backed by clinical data. This innovative research and development path aims to solve the critical need for real science to support claims surrounding medical marijuana. The company’s approach, combined with its strategic alliances, will effectively address the medical community’s concerns over the complexities of cannabis potency, efficacy, quality and content in the…

Continue Reading

MondayDec 11, 2017 3:53 pm

CannabisNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Utilizes Proprietary Advanced Biosynthesis Process to Develop Cannabinoids-based Therapies

InMed Pharmaceuticals (CSE: IN) (OTCQB: IMLFF) remains focused on discovering potential breakthrough cannabinoid-based therapies by utilizing its proprietary cannabinoid biosynthesis process and its bioinformatics drug and disease targeting tool. An article discussing this reads: “Other biopharmaceutical companies may produce cannabinoids in the laboratory using chemical synthesis, but there’s a litany of drug development efforts with synthetic molecules that have failed. The proprietary biosynthesis process used by InMed Pharmaceuticals, Inc.’s (CSE: IN) (OTCQB: IMLFF) is unique. Producing cannabinoids that are identical to naturally occurring compounds is transformative for drug development. By using its proprietary process, InMed is able to manufacture exact…

Continue Reading